Literature DB >> 35525556

Efficient expression, purification, and visualization by cryo-EM of unliganded near full-length HER3.

Devan Diwanji1, Raphael Trenker2, Natalia Jura3, Kliment A Verba4.   

Abstract

Biochemical analyses of membrane receptor kinases have been limited by challenges in obtaining sufficient homogeneous receptor samples for downstream structural and biophysical characterization. Here, we report a suite of methods for the efficient expression, purification, and visualization by cryo-electron microscopy (cryo-EM) of near full-length Human Epidermal Growth Factor Receptor 3 (HER3), a receptor tyrosine pseudokinase, in the unliganded state. Through transient mammalian cell expression, a two-step purification with detergent exchange into lauryl maltose neopentyl glycol (LMNG), and freezing devoid of background detergent micelle, we obtained ~6Å reconstructions of the ~60kDa fully-glycosylated unliganded extracellular domain of HER3 from just 30mL of suspension culture. The reconstructions reveal previously unappreciated extracellular domain dynamics and glycosylation sites.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryo-electron microscopy; HER receptors; Human epidermal growth factor receptors; Membrane proteins; Receptor tyrosine kinases

Mesh:

Substances:

Year:  2022        PMID: 35525556      PMCID: PMC9288109          DOI: 10.1016/bs.mie.2022.03.048

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.682


  35 in total

1.  Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy.

Authors:  Peter B Rosenthal; Richard Henderson
Journal:  J Mol Biol       Date:  2003-10-31       Impact factor: 5.469

2.  ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

Authors:  N J Hellyer; K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

3.  Efficient gene delivery into cell lines and stem cells using baculovirus.

Authors:  Li-Yu Sung; Chiu-Ling Chen; Shih-Yeh Lin; Kuei-Chang Li; Chia-Lin Yeh; Guan-Yu Chen; Chin-Yu Lin; Yu-Chen Hu
Journal:  Nat Protoc       Date:  2014-07-10       Impact factor: 13.491

4.  Structure of Full-Length Human PDGFRβ Bound to Its Activating Ligand PDGF-B as Determined by Negative-Stain Electron Microscopy.

Authors:  Po-Han Chen; Vinzenz Unger; Xiaolin He
Journal:  J Mol Biol       Date:  2015-10-20       Impact factor: 5.469

Review 5.  More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.

Authors:  Devan Diwanji; Tarjani Thaker; Natalia Jura
Journal:  IUBMB Life       Date:  2019-05-02       Impact factor: 3.885

6.  Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.

Authors:  Chafen Lu; Li-Zhi Mi; Michael J Grey; Jieqing Zhu; Elizabeth Graef; Shigeyuki Yokoyama; Timothy A Springer
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

7.  The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion.

Authors:  Shunichi Yokoe; Motoko Takahashi; Michio Asahi; Seung Ho Lee; Wei Li; Daisuke Osumi; Eiji Miyoshi; Naoyuki Taniguchi
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

Review 8.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

9.  A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity.

Authors:  Nicholas M Levinson; Steven G Boxer
Journal:  Nat Chem Biol       Date:  2013-12-01       Impact factor: 15.040

10.  Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta.

Authors:  Ray Yu-Ruei Wang; Yifan Song; Benjamin A Barad; Yifan Cheng; James S Fraser; Frank DiMaio
Journal:  Elife       Date:  2016-09-26       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.